What’s New in Pediatric Melanoma: An Update from the APSA Cancer Committee

Comprehensive review of current pediatric melanoma management showing declining incidence due to prevention efforts. Sentinel lymph node biopsy remains standard for staging, but completion dissection is no longer recommended for node-positive patients who can be monitored with ultrasound instead. Advanced disease treatment increasingly uses targeted immunotherapies, though pediatric-specific trial data remains limited.